Skip to content
Back to Guavy Wire
Stocks

Amgen Builds Indian Research Hub

Instruments
AMGN
Share

Amgen, an American biotechnology firm, is setting up its new Science and Innovation Center at Genome Valley in Hyderabad. This center will become operational by 2027 and will add to Amgen's global research network, taking it to eight laboratories worldwide.

The new facility in India will enable the company to integrate experimental science with data and technology more efficiently. According to Jay Bradner, executive vice president of Research and Development, Artificial Intelligence, and Data at Amgen, this center will expand the way they combine experimental science with data and technology across their global research capabilities.

Hyderabad's strong life sciences ecosystem and deep STEM expertise have been a major factor in Amgen's decision to establish its new innovation site here. 'Hyderabad's strong life sciences ecosystem and deep STEM expertise enable us to apply advanced technologies at scale,' said Naveen Gullapalli, MD, Amgen India.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc